| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.2 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |